Back
BioXcel Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
A 100% Win Rate In 2022
Click to see this exclusive sit-down interview
Sell
33
BTAI
BioXcel Therapeutics
Last Price:
18.31
Seasonality Move:
46.06%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Is it possible to have a crash proof portfolio?
See important Reg A disclosures: Masterworks.com/cdBioXcel Therapeutics Price Quote
$18.31
-0.01 (0.33%)
(Updated: March 25, 2023 at 5:13 AM ET)
BioXcel Therapeutics Key Stats
Sell
33
BioXcel Therapeutics (BTAI)
is a Sell
Day range:
$17.60 - $18.38
52-week range:
$8.80 - $34.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.92%
Volume:
586.7K
Avg. volume:
581.9K
1-year change:
-16.19%
Market cap:
$531.5M
Revenue:
$375K
EPS:
$-5.91
How Much Does BioXcel Therapeutics Make?
Data Unavailable
Is BioXcel Therapeutics Growing As A Company?
Data Unavailable
BioXcel Therapeutics Stock Price Performance
-
Did BioXcel Therapeutics Stock Go Up Last Month?
BioXcel Therapeutics share price went down by -37.96% last month -
Did BTAI's Share Price Rise Over The Last Year?
BTAI share price fell by -16.19% over the past 1 year
What Is BioXcel Therapeutics 52-Week High & Low?
-
What Is BioXcel Therapeutics’s 52-Week High Share Price?
BioXcel Therapeutics has traded as high as $34.13 over the past 52 weeks -
What Is BioXcel Therapeutics’s 52-Week Low Share Price?
BioXcel Therapeutics has traded as low as $8.80 over the past 52 weeks
BioXcel Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioXcel Therapeutics?
-
How Much Debt Does BioXcel Therapeutics Have?
Total long term debt quarterly is $93.1M -
How Much Cash Does BioXcel Therapeutics Have?
Cash and short term investments quarterly total is $193.7M -
What Is BioXcel Therapeutics’s Book Value Per Share?
Book value per share is 2.73
Is BioXcel Therapeutics Cash Flow Positive?
-
What Is BTAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$135.3M -
What Is BioXcel Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $96.2M -
What Is BioXcel Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$139K
BioXcel Therapeutics Return On Invested Capital
Data Unavailable
BioXcel Therapeutics Earnings Date & Stock Price
-
What Is BioXcel Therapeutics's Stock Price Today?
A single share of BTAI can be purchased today for 18.32 -
What Is BioXcel Therapeutics’s Stock Symbol?
BioXcel Therapeutics trades on the nasdaq under the ticker symbol: BTAI -
When Is BioXcel Therapeutics’s Next Earnings Date?
The next quarterly earnings date for BioXcel Therapeutics is scheduled on May 9, 2023 -
When Is BTAI's next ex-dividend date?
BioXcel Therapeutics's next ex-dividend date is March 26, 2023 -
How To Buy BioXcel Therapeutics Stock?
You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioXcel Therapeutics Competitors
-
Who Are BioXcel Therapeutics's Competitors?
Below is a list of companies who compete with BioXcel Therapeutics or are related in some way:
BioXcel Therapeutics Dividend Yield
Data Unavailable
BioXcel Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -37.99% |
| Revenue: | 0% | -77.93% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 52.80 |
| Upside from Last Price: | 188.21% |